ANI Pharmaceuticals Inc (ANIP)
64.59
-0.89
(-1.36%)
USD |
NASDAQ |
Apr 18, 16:00
64.56
-0.02
(-0.04%)
After-Hours: 20:00
ANI Pharmaceuticals Cash from Operations (Quarterly): 44.74M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.74M |
| September 30, 2023 | 32.17M |
| June 30, 2023 | 20.63M |
| March 31, 2023 | 21.42M |
| December 31, 2022 | -4.40M |
| September 30, 2022 | 3.623M |
| June 30, 2022 | -11.48M |
| March 31, 2022 | -18.94M |
| December 31, 2021 | -12.18M |
| September 30, 2021 | -5.402M |
| June 30, 2021 | 0.241M |
| March 31, 2021 | 20.67M |
| December 31, 2020 | -5.709M |
| September 30, 2020 | -1.614M |
| June 30, 2020 | 20.88M |
| March 31, 2020 | 1.71M |
| December 31, 2019 | 4.803M |
| September 30, 2019 | 21.79M |
| June 30, 2019 | 4.744M |
| March 31, 2019 | 14.29M |
| December 31, 2018 | 27.23M |
| September 30, 2018 | 8.319M |
| June 30, 2018 | 8.593M |
| March 31, 2018 | 22.93M |
| December 31, 2017 | 15.80M |
| Date | Value |
|---|---|
| September 30, 2017 | 17.08M |
| June 30, 2017 | 0.001M |
| March 31, 2017 | 6.529M |
| December 31, 2016 | 12.08M |
| September 30, 2016 | 1.084M |
| June 30, 2016 | 3.337M |
| March 31, 2016 | 10.97M |
| December 31, 2015 | 4.702M |
| September 30, 2015 | 10.24M |
| June 30, 2015 | 1.206M |
| March 31, 2015 | 1.12M |
| December 31, 2014 | 10.74M |
| September 30, 2014 | 4.159M |
| June 30, 2014 | 1.954M |
| March 31, 2014 | 5.179M |
| December 31, 2013 | -2.865M |
| September 30, 2013 | -1.631M |
| June 30, 2013 | 3.158M |
| March 31, 2013 | -4.146M |
| December 31, 2012 | -3.164M |
| September 30, 2012 | -7.382M |
| June 30, 2012 | -7.047M |
| March 31, 2012 | -7.689M |
| December 31, 2011 | -10.93M |
| September 30, 2011 | -12.58M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-18.94M
Minimum
Mar 2022
44.74M
Maximum
Dec 2023
7.247M
Average
3.623M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| ADMA Biologics Inc | 17.60M |
| Ligand Pharmaceuticals Inc | 8.065M |
| Dentsply Sirona Inc | 160.00M |
| Allogene Therapeutics Inc | -53.71M |
| Vanda Pharmaceuticals Inc | -3.732M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.779M |
| Cash from Financing (Quarterly) | -11.92M |
| Free Cash Flow | 100.45M |
| Free Cash Flow Per Share (Quarterly) | 2.070 |
| Free Cash Flow to Equity (Quarterly) | 40.17M |
| Free Cash Flow to Firm (Quarterly) | 46.97M |
| Free Cash Flow Yield | 8.54% |